An office building from the 1930s in London was about to be demolished — until remnants of the city’s first Roman basilica ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Institutional investors advised by J.P. Morgan Asset Management in partnership with the principals of Georgia Capital, an Atlanta-based residential investment and development firm, and its affiliated ...

New numbers from the January consumer price index report show a rise in gas, eggs and coffee prices. NBC News’ Brian Cheung ...

After the Milwaukee Common Council adopted a file authorizing the sale of a city-owned tax deed property in the Nash Park neighborhood, Darick Spears is a step closer to expanding ...

The tech giant's fast-growing cloud-computing business decelerated last quarter. Some analysts said tougher comparisons, harsher weather and holiday timing may have put pressure on the fast-casual ...

In the wake of AI, unprecedented demand for data and computing power is outstripping capabilities. This will drive the ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...

Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

RAHWAY, N.J. - Merck & Co ., Inc. (NYSE:MRK) has received a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for its pneumococcal ...

Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday. Terence Flynn has given his Hold rating due to a combination of factors ...